Methotrexate-induced intestinal mucositis delays gastric emptying and gastrointestinal transit of liquids in awake rats;Mucosite induzida pelo metotrexato retarda o esvaziamento gástrico e o trânsito gastrointestinal de líquidos em ratos acordados

Arquivos de Gastroenterologia

Volumn 48, Issue 1, 2011, Pages 80-85

  Soares, Pedro M G ^a   Lopes, Lorena O ^a   Mota, José Maurício S C ^a   Belarmino Filho, José Nelson ^a   Ribeiro, Ronaldo A ^a   de Souza, Marcellus Henrique L P ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Gastric emptying; Gastrointestinal transit; Methotrexate; Mucositis; Rats

Indexed keywords

METHOTREXATE; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CELL DAMAGE; CELL INFILTRATION; CONTROLLED STUDY; DUODENUM; ENZYME ACTIVITY; EPITHELIUM CELL; GASTROINTESTINAL TRANSIT; GRANULOCYTE; ILEUM; INTESTINE MUCOSA; MALE; MUCOSA INFLAMMATION; NEUTROPHIL; NONHUMAN; RAT; SPECTROPHOTOMETRY; STOMACH EMPTYING;

EID: 79956300904     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/s0004-28032011000100016     Document Type: Article

References (24)

1. Bradley PP, Christensen RD, Rothstein G. Cellular and extracellular myeloperoxidase in pyogenic inflammation. Blood. 1982;60:618-22.
2. Cetiner M, Sener G, Sehirli AO, Ekşioǧlu-Demiralp E, Ercan F, Sirvanci S, Gedik N, Akpulat S, Tecimer T, Yeǧen BC. Taurine protects against methotrexate-induced toxicity and inhibits leukocyte death. Toxicol Appl Pharmacol. 2005;209:39-50.
3. Curd CD, Manno JE, Stewart JJ. Effects of methotrexate on intestinal transit in rats. Fundam Appl Toxicol. 1985;5: 991-6.
4. de Jonge WJ, Van den Wijingard RM, The FO, ter Beek ML, Bennink RJ, Tytgat GN, Buijs RM, Reitsma PH, Van Deventer SJ, Boeckxstaens GE. Postoperative ileus is maintained by intestinal immune infiltrates that activate inhibitory neural pathways in mice. Gastroenterology. 2003;125:1137-47.
5. Duncan M, Grant G. Oral and intestinal mucositis-causes and possible treatments. Aliment Pharmacol Ther. 2003;18:853-74.
6. Fan CC, Vitols KS, Huennekens FM. Inhibition of dihydrofolate reductase by methotrexate: a new look at an old problem. Adv Enzyme Regul. 1980;18:41-52.
7. Grosflam J, Weinblatt ME. Methotrexate: mechanism of action, pharmacokinetics, clinical indications, and toxicity. Curr Opin Rheumatol. 1991;3:363-8.
8. Haba T, Sarna SK. Regulation of gastroduodenal emptying of solids by gastropyloroduodenal contractions. Am J Physiol. 1993;264:g261-71.
9. Hickok JT, Roscoe JA, Morrow GR, King DK, Atkins JN, Fitch TR. Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Program Study of 360 cancer patients treated in the community. Cancer. 2003;97:2880-6.
10. Hierholzer C, Kalff JC, Billiar TR, Bauer AJ, Tweardy DJ, Harbrecht BG. Induced nitric oxide promotes intestinal inflammation following hemorrhagic shock. Am J Physiol Gastrointest Liver Physiol. 2004;286:g225-33.
11. Kalff JC, Schraunt WH, Billiar TR, Simmons RL, Bauer AJ. Role of inducible nitric oxide synthase in postoperative intestinal smooth muscle dysfunction in rodents. Gastroenterology. 2000;118:316-27.
12. Kris M, Gralla R, Clark R, Tyson L, Groshen S. Control of chemotherapy-induced diarrhoea with synthetic enkephalin BW942C: a randomised trial with placebo in patients receiving cisplatin. J Clin Oncol. 1988;6:663-8.
13. Minaur NJ, Jefferiss C, Bhalla AK, Beresford JN. Methotrexate in the treatment of rheumatoid arthritis. I. In vitro effects on cells of the osteoblast lineage. Rheumatology. 2002;41:735-740.
14. Miyazono Y, Gao F, Horie T. Oxidative stress contributes to methotrexate-induced small intestinal toxicity in rats. Scand J Gastroenterol. 2004;11:1119-27.
15. Nelson K, Walsh D, Sheehan F. Cancer and chemotherapy-related upper gastrointestinal symptoms: the role of abnormal gastric motor function and its evaluation in cancer patients. Support Care Cancer. 2002;10:455-61.
16. Rang HP, Dale MM, Ritter JM. Pharmacology. 4th ed. Edinburgh: Churchill Livingstone; 1999.
17. Reynell PC, Spray GH. The simultaneous measurement of absorption and transit in the gastro-intestinal tract of the rat. J Physiol 1956;131 452-62.
18. Ribeiro RA, Flores CA, Cunha FQ, Ferreira SH. IL-8 causes in vivo neutrophil migration by a cell-dependent mechanism. Immunology 1991;73:472-7.
19. Riezzo G, Clemente C, Leo S, Russo F. The role of electrogastrography and gastrointestinal hormones in chemotherapy-related dyspeptic symptoms. J Gastroenterol. 2005;40:1107-15.
20. Souza MH, Troncon LE, Cunha FQ, Oliveira RB. Decreased gastric tone and delayed gastric emptying precede neutrophil infiltration and mucosal lesion formation in indomethacin-induced gastric damage in rats. Braz J Med Biol Res. 2003;36:1383-90.
21. Spiller RC. Inflammation as a basis for functional GI disorders. Best Pract Res Clin Gastroenterol. 2004;18:641-61.
22. Teresi ME, Crom WR, Chui KE, Mirro J, Evans WE. Methotrexate bioavailability after oral and intramuscular administration in children. J Pediatr. 1987;110:788-92.
23. Troncon LE, Bennett RJ, Ahluwalia NK, Thompson DG. Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients. Gut. 1994;35:327-32.
24. Vanderhoof JA, Park JH, Mohammadpour H, Blackwood D. Effects of dietary lipids on recovery from mucosal injury. Gastroenterolology. 1990;98:1226-31.